Adamsbrown Wealth Consultants LLC Acquires 75,659 Shares of VanEck Pharmaceutical ETF (NASDAQ:PPH)

Adamsbrown Wealth Consultants LLC raised its holdings in VanEck Pharmaceutical ETF (NASDAQ:PPH) by 102.3% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 149,631 shares of the company’s stock after buying an additional 75,659 shares during the quarter. VanEck Pharmaceutical ETF accounts for about 4.4% of Adamsbrown Wealth Consultants LLC’s investment portfolio, making the stock its 9th largest position. Adamsbrown Wealth Consultants LLC owned about 2.22% of VanEck Pharmaceutical ETF worth $12,910,000 at the end of the most recent quarter.

Several other institutional investors also recently modified their holdings of the company. Bank of Montreal Can lifted its position in shares of VanEck Pharmaceutical ETF by 322.1% during the 2nd quarter. Bank of Montreal Can now owns 15,070 shares of the company’s stock worth $1,407,000 after buying an additional 11,500 shares during the period. Cetera Investment Advisers raised its position in VanEck Pharmaceutical ETF by 12.3% in the 2nd quarter. Cetera Investment Advisers now owns 29,448 shares of the company’s stock valued at $2,694,000 after purchasing an additional 3,237 shares during the last quarter. Sanctuary Advisors LLC bought a new position in VanEck Pharmaceutical ETF in the 2nd quarter valued at $3,827,000. AAFMAA Wealth Management & Trust LLC raised its position in VanEck Pharmaceutical ETF by 155.3% in the 3rd quarter. AAFMAA Wealth Management & Trust LLC now owns 35,319 shares of the company’s stock valued at $3,356,000 after purchasing an additional 21,482 shares during the last quarter. Finally, Stratos Wealth Advisors LLC raised its position in VanEck Pharmaceutical ETF by 40.7% in the 3rd quarter. Stratos Wealth Advisors LLC now owns 13,059 shares of the company’s stock valued at $1,241,000 after purchasing an additional 3,778 shares during the last quarter.

VanEck Pharmaceutical ETF Stock Down 0.7 %

PPH stock opened at $88.92 on Monday. The company has a market cap of $550.41 million, a P/E ratio of 21.04 and a beta of 0.72. VanEck Pharmaceutical ETF has a twelve month low of $84.48 and a twelve month high of $99.51. The business has a fifty day moving average of $87.80 and a 200-day moving average of $91.81.

VanEck Pharmaceutical ETF Increases Dividend

The company also recently announced a dividend, which was paid on Monday, December 30th. Stockholders of record on Friday, December 27th were given a dividend of $0.411 per share. The ex-dividend date of this dividend was Friday, December 27th. This is an increase from VanEck Pharmaceutical ETF’s previous dividend of $0.36.

VanEck Pharmaceutical ETF Profile

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.